To include your compound in the COVID-19 Resource Center, submit it here.
Amgen stopped a Phase III trial of OncoVEX GM-CSF to treat SCCHN. Amgen did
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury